Induction of a unique gene expression profile in primary human hepatocytes by hepatitis C virus core, NS3 and NS5A proteins

被引:29
作者
Budhu, A.
Chen, Y.
Kim, J. W.
Forgues, M.
Valerie, K.
Harris, C. C.
Wang, X. W. [1 ]
机构
[1] NCI, NIH, Ctr Canc Res, Human Carcinogenesis Lab, Bethesda, MD 20892 USA
[2] NCI, NIH, Ctr Canc Res, Genet Branch, Bethesda, MD 20892 USA
[3] Virginia Commonwealth Univ, Med Coll Virginia, Dept Radiat Oncol, Richmond, VA 23298 USA
关键词
D O I
10.1093/carcin/bgm075
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocellular carcinoma (HCC) is a fatal disease and hepatitis B and C viruses (HBV and HCV) are considered as major causative factors for the development of HCC. We have conducted gene expression profiling studies to search for potential target genes responsible for HCV-mediated HCC. Adenoviruses encoding core (HCV structural protein), NS3 and NS5A [HCV non-structural (NS) proteins] were generated and infected individually or together in freshly isolated primary human hepatocytes. An adenovirus harboring the oncogenic HBV protein, HBx, was included for comparison. A microarray platform of over 22 000 human oligos was analyzed to seek out significant differentially expressed genes among these viral proteins. We also compared these gene expression profiles with those obtained from HCV-infected liver samples from chronic liver disease (CLD) patients and HCV-related HCC. We found that HCV-related proteins largely induce unique genes when compared with RBx. In particular, interferon-inducible gene 27 (IFI27) was highly expressed in HCV or core-infected hepatocytes and HCV-related CLD or HCC, but was not significantly expressed in HBx-infected hepatocytes or HBV-related CLD or HCC, indicating that IFI27 may play a role in HCV-mediated HCC. In conclusion, our results suggest that HBV and HCV promote HCC development mainly through different mechanisms.
引用
收藏
页码:1552 / 1560
页数:9
相关论文
共 34 条
[1]   Expression profiling of liver cell lines expressing entire or parts of hepatitis C virus open reading frame [J].
Aizaki, H ;
Harada, T ;
Otsuka, M ;
Seki, N ;
Matsuda, M ;
Li, YW ;
Kawakami, H ;
Matsuura, Y ;
Miyamura, T ;
Suzuki, T .
HEPATOLOGY, 2002, 36 (06) :1431-1438
[2]   Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection [J].
Bièche, I ;
Asselah, T ;
Laurendeau, I ;
Vidaud, D ;
Degot, C ;
Paradis, V ;
Bedossa, P ;
Valla, DC ;
Marcellin, P ;
Vidaud, M .
VIROLOGY, 2005, 332 (01) :130-144
[3]   Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) [J].
Bréchot, C ;
Gozuacik, D ;
Murakami, Y ;
Paterlini-Bréchot, P .
SEMINARS IN CANCER BIOLOGY, 2000, 10 (03) :211-231
[4]   SELECTIVE G-MUTATION TO T-MUTATION OF P53 GENE IN HEPATOCELLULAR-CARCINOMA FROM SOUTHERN AFRICA [J].
BRESSAC, B ;
KEW, M ;
WANDS, J ;
OZTURK, M .
NATURE, 1991, 350 (6317) :429-431
[5]  
BUDHU A, 2003, RECENT RES DEV MOL B, P97
[6]  
Carr Brian I., 1997, P1087
[7]   Epidemiological characteristics and risk factors of hepatocellular carcinoma [J].
Chen, CJ ;
Yu, MW ;
Liaw, YF .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1997, 12 (9-10) :S294-S308
[8]   Hepatitis C virus biology [J].
Giannini, C ;
Bréchot, C .
CELL DEATH AND DIFFERENTIATION, 2003, 10 (Suppl 1) :S27-S38
[9]   Hepatitis C virus core protein regulates p300/CBP co-activation function.: Possible role in the regulation of NF-AT1 transcriptional activity [J].
Gómez-Gonzalo, M ;
Benedicto, I ;
Carretero, M ;
Lara-Pezzi, E ;
Maldonado-Rodriguez, A ;
Moreno-Otero, R ;
Lai, MMC ;
López-Cabrera, M .
VIROLOGY, 2004, 328 (01) :120-130
[10]   The role of cytotoxic T cells and cytokines in the control of hepatitis B virus infection [J].
Guidotti, LG .
VACCINE, 2002, 20 :A80-A82